The Medical Letter on Drugs and Therapeutics
Vaccines for Travelers
November 24, 2014 (Issue: 1456)
- Adult immunization. Treat Guidel Med Lett 2014; 12:39.
- General recommendations on immunization - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60(2):1.
- RM Klevens et al. The evolving epidemiology of hepatitis A in the United States: incidence and molecular epidemiology from population-based surveillance, 2005-2007. Arch Intern Med 2010; 170:1811.
- S Iwarson et al. Excellent booster response 4 to 8 years after a single primary dose of an inactivated hepatitis A vaccine. J Travel Med 2004; 11:120.
- Centers for Disease Control and Prevention. CDC Health Information for International Travel 2014. The Yellow Book. Chapter 3, Hepatitis A. Available at: www.cdc.gov. Accessed November 13, 2014.
- DF Johnson et al. Hepatitis B and C infection in international travelers. J Travel Med 2013; 20:194.
- R Steffen. Influenza in travelers: epidemiology, risk, prevention, and control issues. Curr Infect Dis Rep 2010; 12:181.
- Influenza vaccine for 2014-2015. Med Lett Drugs Ther 2014; 56:97.
- Centers for Disease Control and Prevention (CDC). Use of northern hemisphere influenza vaccines by travelers to the southern hemisphere. MMWR Morb Mortal Wkly Rep 2009; 58:312.
- SL Hills et al. Japanese encephalitis in travelers from non-endemic countries, 1973-2008. Am J Trop Med Hyg 2010; 82:930.
- E Mirzaian et al. Mosquito-borne illnesses in travelers: a review of risk and prevention. Pharmacotherapy 2010; 30:1031.
- A new Japanese encephalitis vaccine (Ixiaro). Med Lett Drugs Ther 2009; 51:66.
- Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices, 2013. MMWR Morb Mortal Wkly Rep 2013; 62:898.
- PA Gastañaduy et al. Measles - United States, January 1-May 23, 2014. MMWR Morbid Mortal Wkly Rep 2014; 63:496.
- HQ McLean et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(RR-4):1.
- AC Cohn et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(RR-2):1.
- A new conjugate meningococcal vaccine (Menveo). Med Lett Drugs Ther 2010; 52:59.
- JR MacNeil et al. Use of MenACWY-CRM vaccine in children aged 2 through 23 months at increased risk for meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2013 MMWR Morb Mortal Wkly Rep 2014; 63:527.
- Meningococcal group B vaccine. Med Lett Drugs Ther 2014 (in press).
- GS Wallace et al. Interim CDC guidance for polio vaccination for travel to and from countries affected by wild poliovirus. MMWR Morb Mortal Wkly Rep 2014; 63:591.
- C Malerczyk et al. Imported human rabies cases in Europe, the United States, and Japan, 1990 to 2010. J Travel Med 2011; 18:402.
- CE Rupprecht and RV Gibbons. Clinical practice. Prophylaxis against rabies. N Engl J Med 2004; 351:2626.
- CE Rupprecht et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2010; 59(RR-2):1.
- M Uwanyiligira et al. Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations. Clin Infect Dis 2012; 55:201.
- Prevention and treatment of pertussis. Med Lett Drugs Ther 2012; 54:73.
- MF Lynch et al. Typhoid fever in the United States, 1999-2006. JAMA 2009; 302:859.
- JA Whitaker et al. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. J Travel Med 2009; 16:46.
- JE Staples et al. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59(RR-7):1.
- World Health Organization. Yellow fever vaccination. Weekly epidemiological record 2013; 20:208. Available at www.who.int. Accessed November 13, 2014.
- Collaborative group for studies on yellow fever vaccines. Duration of post-vaccination immunity against yellow fever in adults. Vaccine 2014; 32:4977.
- RE Thomas et al. How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria? Vaccine 2013; 31:6201.
- RE Thomas et al. The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review. Am J Trop Med Hyg 2012; 86:359.
- MF Farez and J Correale. Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis. Arch Neurol 2011; 68:1267.
- S Kuhn et al. Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk. CMAJ 2011; 183:E243.
- RC Charles and ET Ryan. Cholera in the 21st century. Curr Opin Infect Dis 2011; 24:472.
- Cholera vaccines: WHO position paper. Wkly Epidemiol Rec 2010; 85:117.
- A Banzhoff et al. Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas. Travel Med Infect Dis 2008; 6:331.
- U Kunze. Is there a need for a travel vaccination against tick-borne encephalitis? Travel Med Infect Dis 2008; 6:380.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.